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Background: Iatrogenic hypothyroidism might worsen the prognosis of cats with azotemic CKD
after thyroidectomy. Varying thyroxine concentrations influence utility of creatinine in assessing
renal function. Symmetric dimethylarginine (SDMA) has limited studies in cats with changing
thyroid status.
Objectives: Thyroid status is stable 6 months post-thyroidectomy. Symmetric dimethylargi-
nine and creatinine are linearly associated without influence from total thyroxine concentra-
tion (tT4).
Animals: Electronic records of 2 first opinion practices were searched using the term “thyroidec-
tomy” to include 81 client-owned cats that had undergone bilateral thyroidectomy.
Methods: Retrospective cross-sectional study assessing thyroid hormone concentrations of
68 cats within 6 months of surgery. A longitudinal study of thyroid status in 23 cats with
>18 months follow-up post-thyroidectomy. A generalized estimating equation assessed the
associations of bodyweight, tT4 and creatinine concentrations on SDMA concentration.
Results: Sixty-eight cats had follow-up within 6 months. Fifteen cats (22%) had persistent, or
recurrent, hyperthyroidism and 33 cats (49%) were hypothyroid. Twenty-three of the euthyr-
oid/hypothyroid cats had long-term follow-up (595-1955 days); 4 cats (17%) remained hypothy-
roid, 19 cats (83%) were euthyroid (often transiently), and 9 of 23 cats (44%) developed
recurrent hyperthyroidism. Symmetric dimethylarginine and creatinine were linearly associated,
but hyperthyroid cats had higher SDMA concentrations, relative to creatinine (P = .003).
Conclusions and Clinical Importance: Cats have changes in thyroid function for years after bilat-
eral thyroidectomy, with a high incidence of recurrent hyperthyroidism. Both SDMA and creati-
nine are affected by thyroxine concentrations, and the effect is greater in hyperthyroid cats.
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1 | INTRODUCTION
Hyperthyroidism (caused by adenomatous hyperplasia)1 and chronic kid-
ney disease are common in geriatric cats. Azotemia often develops
when glomerular filtration rate (GFR) decreases after treatment for
hyperthyroidism.2,3 In 1 study, cats that were both hypothyroid and azo-
temic after treatment had shorter survival than nonazotemic hypothy-
roid cats.4 Reversal of hypothyroidism is associated with improvement
in azotemia in most cats.5 Consequently “overtreatment” of hyperthy-
roidism is avoided, especially if cats are concurrently azotemic.6 How-
ever, irreversible treatment modalities (radioactive iodine [RAI] and
surgery) cannot always avoid causing hypothyroidism.7–9
Thyroidectomy offers a potentially permanent cure for hyper-
thyroidism without requiring specialist equipment, making it widely
Abbreviations: BCS, body condition score; RAI, radioactive iodine; TSH, thyroid
stimulating hormone; tT4, total thyroxine concentration; GEE, generalized esti-
mating equation; GFR, glomerular filtration rate; USG, urine-specific gravity;
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available in general practice. Previous reports of thyroidectomy pre-date
interest in posttreatment hypothyroidism, focusing mainly on postopera-
tive hypocalcaemia7,8,10,11 or recurrence of hyperthyroidism.12,13 Over-
all, 5 original studies report recurrence rates for hyperthyroidism of
between 5% and 27%,7,8,10–13 between 3 and 59 months after surgery.
The highest rate of recurrence (3/11 cats) was in a report of unilateral
surgery,7 with recurrence rates otherwise reported as 5%-11%.8,10,12,13
All were in referral practice and preoperative scintigraphy was used rou-
tinely in 2 studies,10,12 or only in cats with recurrent disease.8,13 Recur-
rence was identified at the surgical site, especially with intracapsular
technique,8,10 and ectopic foci.12,13 Supplementation of levothyroxine
after bilateral thyroidectomy was discontinued after 3-6 months if no
evidence of lethargy or haircoat change was seen.8 Cats undergoing uni-
lateral thyroidectomy were not supplemented despite low total thyrox-
ine (tT4) levels for several months after surgery.8 Low tT4 was noted in
25% (26/106) of cats undergoing bilateral thyroidectomy, and 13 (50%)
of cats were given long-term levothyroxine supplementation, but no
clinical signs were seen.10 No study measured thyroid stimulating hor-
mone (TSH), and long-term only recurrence of hyperthyroidism, not
hypothyroidism, was reported. 7,8,10–14
Assessment of renal function in geriatric cats with changing thyroid
status poses many challenges. After treatment of cats with RAI, GFR
decreased after 1 month and did not decrease further at 6 months, but
creatinine increased for 3 months before stabilizing.3 A possible expla-
nation is increasing muscle mass (and creatinine generation) in treated
hyperthyroid cats.15 In addition, thyroxine increases renal blood flow
and GFR by RAAS activation, increased sympathetic nervous activity,
and decreased peripheral vascular resistance.16 Control of hyperthyroid-
ism can therefore be expected to cause some increase in creatinine, as
GFR decreases. Symmetric dimethylarginine (SDMA) correlates with
GFR17 and creatinine.18,19 Lean body mass had no effect on SDMA, in
contrast to creatinine,20,21 and so SDMA may provide a useful indicator
of renal function in cats before and after treatment for hyperthyroidism.
The first, cross-sectional, study (i) aimed to report the preva-
lence of hypothyroidism in cats in the first 6 months after bilateral
thyroidectomy in first-opinion practice. A second, longitudinal, study
(ii) aimed to report long-term follow-up of a subset of cats to deter-
mine if postsurgical hypothyroidism is permanent or transient, and
the rate of recurrence of hyperthyroidism. All samples from both of
the initial studies were analyzed with (iii) the aim of assessing the
influence of changing thyroid status on the relationship between
SDMA and creatinine.
2 | MATERIALS AND METHODS
2.1 | Case selection
Cases were selected from geriatric feline clinics (recruiting cats over
9 years old) held at 2 first opinion practices (People's Dispensary for
Sick Animals, Bow and the Beaumont Animal Hospital, Camden). Elec-
tronic records were searched using the term “thyroidectomy” during
the time period from December 1, 1996, to August 30, 2015. Inclu-
sion criteria were recorded dates for bilateral thyroidectomy surgery,
performed either as 1 procedure or 2 staged unilateral procedures,
and the availability of stored plasma samples for retrospective analysis
of SDMA and TSH (and creatinine or tT4 if this had not been mea-
sured previously).
Inclusion in the cross-sectional study, to determine the prevalence
of hypothyroidism, required a single stored plasma sample, collected
within 6 months of surgery. Inclusion criteria for the longitudinal study,
of changes in thyroid and renal markers after surgery, required addi-
tional samples to be available for at least 18 months after surgery. Cats
that developed recurrent hyperthyroidism were followed only up to the
point that this developed, and the cat had additional treatment, usually
with methimazole or carbimazole. The follow-up period for the longitu-
dinal study was determined by the available samples until the cats died,
were lost to follow-up or had reached the study end point (August
30, 2015).
Clinical data recorded included age, sex, breed, dates of thyroidec-
tomy, tT4 and TSH concentrations, creatinine concentrations, urine-
specific gravity (USG), body condition score (BCS), and body weight.
Cats were defined as hypothyroid if their tT4 was below the reference
range (<10 nmol/L) with TSH above 0.15 ng/mL concurrently. This cut-
off was established in the author's clinic previously, from 90 healthy
cats over 9 years of age.22 Cats considered euthyroid had tT4 within
the reference range (10-55 nmol/L) and TSH <0.15 ng/mL. Cats with
plasma tT4 above the laboratory reference range (>55 nmol/L) were
considered hyperthyroid.
2.2 | Blood sample analysis
Jugular venous blood samples and urine samples collected by cysto-
centesis (where performed) were obtained as part of the routine oper-
ation of the clinic and with the informed consent of the owner
(CRERB 2013/1258). Blood samples were collected into heparinized
tubes, refrigerated at 4C and separated by centrifugation at 2016g
for 10 minutes within 6 hours of collection. After separation, heparin-
ized plasma samples were stored at −80C, unless utilized for immedi-
ate analysis.
Analysis of all blood samples was by a single reference laboratory
(IDEXX reference laboratory, Wetherby, United Kingdom). In most
instances, measurement of tT4 and, on most occasions, creatinine was
performed contemporaneously at the direction of the treating clini-
cian, but occasionally this measurement was done retrospectively for
the present study. Urine-specific gravity was analyzed by in-house
refractometer at the time of sample collection.
Archived heparinized plasma samples were obtained from all cats
(where possible) at a visit within 6 months of thyroidectomy. These
were submitted for TSH and SDMA (and tT4 or creatinine if required)
measurement at the same reference laboratory (IDEXX reference labo-
ratory). Cats with long-term follow-up (more than 18 months) had,
where possible, samples from 6-month intervals submitted to the same
external reference laboratory (IDEXX reference laboratory) for tT4,
TSH, SDMA, and creatinine measurement. Total T4 was measured
using a chemiluminescent assay, and TSH concentrations were mea-
sured by the Immulite canine TSH assay (Siemens, Camberley, United
Kingdom) as previously validated.20
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2.3 | Data analysis
Graphical and statistical analysis were performed using commercial
computer software (IBM SPSS Statistics Version 22 and GraphPad
Prism 7 for Mac). Normality was assessed by examination of histo-
gram and (where necessary) by Shapiro-Wilk test. Numerical data are
reported as median and range, and categorical data are reported as
percentages. Statistical significance was defined as P < .05.
The time since thyroidectomy was calculated from the date of the
second surgery for those cats that had staged procedures. Azotemia
was defined as plasma creatinine measurement greater than the labo-
ratory reference range (2 mg/dL, 177 μmol/L). This reference range
was that used by IDEXX laboratories, United Kingdom, during the
period of analysis. For the cross-sectional study (i), chi-square test
was used to compare the proportion of cats that were hypothyroid
after simultaneous (bilateral) and staged (unilateral) surgeries.
For the longitudinal study (ii) changes in tT4 and TSH were
assessed by Kaplan-Meier time-to-event analysis, with censoring if
the cat died or was lost to follow-up. Wilcoxon signed-rank test was
performed to assess whether the time for normalization of tT4 and
TSH concentrations were significantly different.
For the SDMA study (iii), the relationship between SDMA and creat-
inine and other factors that might alter this relationship (body weight,
BCS, and thyroid status) were assessed using both cross-sectional and
longitudinal data. Given that not all cats had longitudinal follow-up, a
generalized estimating equation (GEE) with working correlation matrix
was used to account for correlation between those with repeated mea-
sures. For this part of the analysis, tT4 concentrations only were used to
categorize cats at each time point using the IDEXX laboratory's reference
range; hypothyroid (tT4 < 10 nmol/L), euthyroid (tT4 10-55 nmol/L), or
hyperthyroid (tT4 > 55 nmol/L). Thyroid stimulating hormone concentra-
tions were not used to categorize cats in this analysis as the combination
of tT4 and TSH in this postsurgical population resulted in many samples
having uncategorizable thyroid status, often because the TSH remained
elevated for a period of time after the tT4 normalized. In the univariable
GEE analysis, SDMA was used as the dependent variable, a linear scaled
response as the type of model, and the covariates/factors that were
included were creatinine, body weight, BCS, and thyroid status (hypothy-
roid, euthyroid, and hyperthyroid). Only variables with P < .1 and their
interactions (ThyroidStatus × Creatinine, ThyroidStatus × BodyWeight,
and BodyWeight × Creatinine) were included in the multivariable analy-
sis. Backward elimination was used to develop the final model.
3 | RESULTS
3.1 | Cross-sectional study
Eighty-one cats were identified as having undergone bilateral thyroidec-
tomy. Three cats were excluded from the analysis as they had no
recorded date for surgery, 3 cats were lost to follow-up immediately
after surgery, and a further 7 cats had no stored samples available.
Sixty-eight cats were therefore included in the cross-sectional study. All
cats were neutered, and no cats were of pedigree breeds. There were
29 male cats (41%) and 39 female cats (57%) included. The age at sur-
gery was 14.9 (9.3-20.4) years. The age of 4 cats was unknown. The
cats' weight at surgery was 3.55 (2.1-9.3) kilograms; preoperative weight
was not recorded for 3 cats. In most instances (60/68, 88%), medical
stabilization was performed (with varying success) before surgery. Total
T4 measurement before surgery (within 2 months) was available for
45 cats and revealed that 24 cats were controlled (tT4 < 55 nmol/L),
12 of which had low tT4 on medication (tT4 < 10 nmol/L), with 21 cats
still hyperthyroid (tT4 103 nmol/L, 56-281 nmol/L) despite medication.
Blood testing was not performed immediately before surgery in 23 cats,
because the hyperthyroidism was overtly uncontrolled. This was based
on the severity of clinical signs or, more often, as the owner was known
not to be able to administer the medication. In all cases, hyperthyroidism
was documented biochemically before treatment, but in some cats this
was a considerable interval before surgery. Thyroidectomy was per-
formed as a staged procedure in 40 of 68 cats with a median intraopera-
tive interval of 258 (16-2086) days.
In the first 6 months post-surgery, hypothyroidism was documen-
ted in 33 of 68 (49%) cats, 15 of 68 (22%) cats continuing to be hyper-
thyroid and 13 of 68 (19%) cats euthyroid (Figure 1). In 7 cats, thyroid
status was uncertain; in 3 cats, the uncertainty was because although
tT4 was in the euthyroid range (16.7-20.5 nmol/L), TSH was increased
(0.8-1.11 ng/mL) possibly consistent with subclinical hypothyroidism,
and in 4 cats this was because tT4 was low (4-8.8 nmol/L) but so was
TSH concentration (0.04-0.12 ng/mL) consistent with sick euthyroid-
ism. The prevalence of overt hypothyroidism in the first 6 months
was greater in cats that had both thyroid glands removed in a single
surgical procedure (19/28, 67.9%) compared with cats having staged
thyroidectomies (16/40, 40%, P = .04).
3.2 | Longitudinal study
Long-term follow-up was available for 23 cats (range 595-1955 days).
Of these cats, the cross-sectional study had documented that 16 cats
had low tT4 after surgery (2 of which were unclassified with normal
TSH but low tT4), and 7 cats had normal tT4 (2 of which were unclas-
sified with high TSH but normal tT4); Figure 2. Twelve of the cats
FIGURE 1 Flowchart of cats included in a cross-sectional study
evaluating thyroid status in the first 6 months after bilateral
thyroidectomy in first opinion practice
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(12/16, 75%) with low tT4 initially had normalization of tT4 concen-
trations (>10 nmol/L and <55 nmol/L), 234 days (193-992 days) after
surgery. Six (50%) of these cats had recurrence of hyperthyroidism. In
1 cat, tT4 increased from below 10 nmol/L to above 55 nmol/L when
the cat was next presented (an interval of 476 days), but the other
5 cats were within the euthyroid range for between 168 and 637 days
before hyperthyroidism recurred.
In total, 10 of 23 cats became hyperthyroid after bilateral thyroid-
ectomy (including 6 cats with a tT4 initially <10 nmol/L), giving a longer
term recurrence rate of hyperthyroidism post-surgery of 43.5%. The
length of follow-up to hyperthyroidism recurrence was 726 (208-1049)
days, and the follow-up of cats without recurrence was 992 (607-1955)
days. Follow-up was until death in 22 of 23 cats, only 1 was lost to
follow-up. Hyperthyroidism recurred at prolonged periods after surgery
(1 cat at <1 year, 3 between 1 and 2 years, and 6 at >2 years after
surgery).
Sixteen cats showed a pattern of TSH increase after surgery, with
a prolonged time between restoration of normal T4 and resolution of
increased TSH concentrations (Figure 3). The time for documentation
of tT4 within reference range in all 23 cats was 412 days (range
21-1955 days) and for TSH to return to reference range was 552 days
(34-1955 days); Figure 4. A Wilcoxon signed rank test confirmed a
significant difference (P = .03).
3.3 | SDMA study
Symmetric dimethylarginine and creatinine were linearly associated
(Figure 5), but the classification of renal status (azotemic/nonazotemic
or normal/increased SDMA) was discordant in many cases. Symmetric
dimethylarginine was above the reference range (>14 μg/dL) in 30%
(45/151) of samples where creatinine was within reference range
(≤2.0 mg/dL, ≤177 μmol/L). Urine-specific gravity was available for
33 of these 45 samples, 6 of which (13%), were >1.035. In the 27 other
samples, urine was ≤1.014 in 3 of 33, 1.015-1.024 in 13 of 33, and
1.025-1.034 in 11 of 33 samples. Four (9%) of the discordant samples
were from hyperthyroid cats. In 5% (8/151) of samples, creatinine was
increased (>2.0 mg/dL, >177 μmol/L) with normal SDMA (≤14 μg/dL).
FIGURE 2 Longitudinal study outcome; classification of cats in the
first 6 months after bilateral thyroidectomy surgery and their change
in classification at the time of loss to follow-up or death
FIGURE 3 Illustrative changes in tT4 and TSH over time for 1 cat
after bilateral thyroidectomy surgery in first opinion practice. The
dotted line indicates the boundary of the reference ranges (tT4 over
10nmol/L, TSH <0.15ng/mL)
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FIGURE 4 Kaplan-Meier time-to-event analysis, demonstrating the
first time at which normalization of tT4 (>10 nmol/L) and TSH
(<0.15 ng/mL), respectively, was documented in 23 cats after bilateral
thyroidectomy surgery. All cats had blood samples analyzed within
6 months of surgery and every 6 months afterwards where possible.
Seven cats that died without reaching these levels were censored
from the analysis, indicated by the circles on the graph. The 2 curves
are not significantly different (P = .20) on log-rank analysis
FIGURE 5 Samples from 68 cats that underwent treatment of
hyperthyroidism by bilateral thyroidectomy, with symmetric
dimethylarginine (SDMA) and creatinine measured concurrently both
before and after surgery. In total, 151 data points plotted, some of which
are repeated measures from the same cats. The dotted gridlines
represent the reference ranges for creatinine (2.0 mg/dL, 177 μmol/L)
and SDMA (14 μg/dL), respectively. Samples are categorized by tT4
concentration and lines of best fit plotted using intercept and slope
generated from a generalized estimating equation
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Urine-specific gravity was measured concurrently in 5 of the 8 cats
with increased creatinine and normal SDMA and was <1.035 in all of
them (1.015-1.024 in 4/5, 1.025-1.034 in 1/5). All 8 cats had concur-
rent tT4 concentrations within or below the reference range.
Analysis of variables influencing SDMA concentrations utilizing a
GEE revealed significant influence on SDMA by thyroid status (P = .01),
creatinine (P < .001), and their interaction (ThyroidStatus × Creatinine;
P = .003). Bodyweight had a significant effect on SDMA alone (P = .008)
but not as an interaction with other variables (ThyroidStatus × Body-
Weight; P = .31, BodyWeight × Creatinine; P = .61). Body condition
score was not significant in univariable analysis (P = .15). The effect of
creatinine on SDMA concentration was greater in hyperthyroid cats than
in cats that were euthyroid or hypothyroid (Table 1).
4 | DISCUSSION
Recurrent hyperthyroidism occurs in 5%-11% of cats after bilateral
thyroidectomy,8,10,12,13 as compared to recurrence in our population of
22% in the short term (within 6 months of surgery), with a further 44%
over the long-term (up to 1049 days). Results of the present study are
likely to be more representative of those achieved in first opinion prac-
tice than are previous reports. Recurrence is more frequently associated
with a particular surgical (intracapsular) technique10 or in the presence
of ectopic thyroid tissue.12 There was no consistent recording of the
surgical technique used, and the experience of the surgeons was also
variable, including relatively new graduates and experienced practi-
tioners; and therefore, the higher recurrence rate is likely to be the
result of multiple variables, preventing direct comparison. These cats
also did not undergo presurgical screening (technetium scintigraphy) for
ectopic tissue, estimated to affect 4%-12% of cats, or carcinoma, esti-
mated at 2%.23 These factors might have combined to result in a high
incidence of postoperative hyperthyroidism in the present study. Radio-
iodine and surgery have both been portrayed as “permanent” cures for
hyperthyroidism, often chosen to avoid long-term medication, as diffi-
culty in administering medication was a factor in the choice of radio-
iodine treatment for 43.9% of owners.24 If the present study can be
considered representative of the results achieved in first opinion
practice, then the notion that thyroidectomy offers a permanent “cure”
for hyperthyroidism should perhaps be reconsidered. However, the
recurrence of hyperthyroidism after thyroidectomy is a concern for only
11.5% of owners seeking radioiodine treatment.24 Interestingly, despite
the anesthetic risk of surgery in geriatric cats, the population included
here had a median age of 14.9 years and the oldest cat undergoing sur-
gery was 20.4 years old, suggesting that perhaps this risk does not dis-
courage owners as much as previously thought. This may reflect the
expense of radioiodine in comparison to surgery, or a lack of awareness
of nonsurgical options, demonstrated by 53.3% of hyperthyroid cat
owners being unaware of RAI as an option.24
Many cats in the present study (40/68) had staged procedures
(2 unilateral surgeries), in some cases with a prolonged time between
them. This is despite the presence of bilateral disease occurring in the
majority of cats (62.9-66.1%).23,25 The reason for staging of the primary
procedure is thought to be due to concerns for iatrogenic hypoparathy-
roidism and subsequent hypocalcaemia after surgery. Staged bilateral
thyroidectomy does reduce the incidence of hypocalcaemia, though the
authors did not suggest that staged procedures should be performed
routinely.7 Others have suggested a preference for staged surgery to
allow resolution of damage to parathyroid function.26 A larger propor-
tion of cats became hypothyroid after nonstaged bilateral procedures,
which could reflect recovery of some function of the residual tissue
after thyroidectomy occurring in the interim between procedures.14
Long term, this study documents restoration of euthyroidism in
39% of cats after bilateral thyroidectomy, although two-thirds of
these had previously had been hypothyroid. Success rates in the pub-
lished literature are quoted as between 66% and 90%,10,12,13 but are
difficult to compare, as the definitions of euthyroidism vary (with
some studies including tT4 levels below the reference range), and
follow-up periods are generally short. Comparison of these figures
with published follow-up from radioiodine treatment, 1 of the main
alternative options for owners, suggests that cats treated surgically
in first opinion practice have a higher incidence of recurrent or
persistent hyperthyroidism (compared to 1.5%-9.5%) but comparable
rates of hypothyroidism (between 4% and 36% depending on the
study).16,25,27 However, our short-term prevalence of hypothyroidism
(49%) is based on a single time point for each cat and so could have
been too soon or too long after surgery to document cats with tran-
sient hypothyroidism or those for which the increase in TSH after sur-
gery is delayed.
Changes in thyroid status occurred at prolonged periods after sur-
gery. This was true not just in cats that had recurrent hyperthyroidism
(which could be explained by novel adenomatous transformation)14 but
also in 3 cats in which normalization of tT4 was only seen after 604-890
days of hypothyroidism. These 3 cats had prolonged follow-up in their
euthyroid state (2-4 years), suggesting that it was not imminent hyper-
thyroidism causing the rise in tT4. Previous studies11,16,25 have mostly
focused on follow-up only in the initial 6-12 months post-treatment,
but the present study suggests that longer term follow-up of cats
remains important. Thyroid function can, and frequently does, change
dramatically at time periods far beyond 6 months after surgery. Unfor-
tunately, it is not possible to confirm prevalence for the whole popula-
tion, as some cats lacked long-term follow-up, but in total 25 of the
68 cats initially enrolled developed recurrent hyperthyroidism. As with
TABLE 1 Analysis of the influence of creatinine and thyroid status on
symmetric dimethylarginine concentrations, using a generalized
estimating equation
Variable Coefficient SE P
Bodyweight −0.67 0.25 .008
Thyroid status (intercept) .01
Hyperthyroid −5.61 5.25
Euthyroid 5.09 3.66
Hypothyroid 9.62 1.79
Thyroid status × creatinine (regression coefficient of creatinine) .003
Hyperthyroid 15.16 3.05
Euthyroid 7.54 2.09
Hypothyroid 4.95 0.50
Data were obtained from 68 cats that had a bilateral thyroidectomy in first
opinion practice; in total, 151 measurements were used. Creatinine, body-
weight, thyroid status, and an interaction term of creatinine × thyroid sta-
tus were included in the final model.
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many retrospective studies, our follow-up has limitations; some cats
were presented more regularly than others, and many cats had no
follow-up beyond 18 months, limiting the numbers enrolled and poten-
tially introducing a selection bias in favor of those cats still symptomatic
for their disease. In addition, it is likely that those cats undergoing thy-
roidectomy are not a random and representative sample of the affected
population. The reason for choosing this treatment in the first place is
frequently a failure to control their clinical signs medically, increasing
the proportion of cats with more severe disease and potentially increas-
ing recurrence rates.
Thyroid stimulating hormone declined rapidly to undetectable
concentrations in hyperthyroid cats, often preceding development
of hyperthyroidism (based on serum tT4) by 6-12 months, in agree-
ment with a previous finding of increased risk of hyperthyroidism in
cats with undetectable TSH.22 Seven of 9 cats with undetectable
TSH progressed to hyperthyroidism, with a further 1 having border-
line thyroid status (tT4, 54.2 nmol/L) at the end of follow-up. The
remaining cat, however, had low or undetectable TSH concentra-
tions (0.015-0.04 ng/dL) for the whole follow-up period (1014 days),
with low tT4, and development of severe concurrent renal disease
only late in follow-up. Thyroid stimulating hormone suppression
after radioiodine treatment in 7 of 8 cats in a previous study lasted
for <3 months,4 and therefore the presence of persistent low TSH in
this cat is difficult to explain. This variability in the relationship of T4
and TSH may pose a challenge when using TSH concentrations to char-
acterize thyroid status after treatment, for diagnosis of nonthyroidal ill-
ness, occult hyperthyroidism, or subclinical hypothyroidism.28–30
The findings of the present study impact upon the timing of deci-
sions to initiate levothyroxine supplementation, now a recommendation
for all azotemic cats with low tT4.6 Lack of suppression of TSH concen-
trations, in cats with normal tT4, has been suggested to indicate sub-
clinical hypothyroidism,31 therefore necessitating an increased dose of
thyroid hormone. In cats reported here, TSH remained above our refer-
ence range22 for prolonged periods after normalization of tT4. If this
sustained increase in TSH were to be ascribed to occult hypothyroid-
ism, then some cats with normal T4 would also warrant supplementa-
tion. However, that abstract used 0.5 ng/dL as their cutoff for TSH, a
higher value than that utilized here, and so cats would have fallen into
this range more rapidly. In a further study, the reported reference range
for TSH was 0.03-0.3 ng/mL.32 However, the origin of that reference
range is unclear, and the 131 clinically normal euthyroid cats in that
study had TSH concentrations of 0.04 ng/mL (interquartile range,
0.02-0.07 ng/mL), which suggests that a narrower reference range may
be appropriate for healthy cats. Clearly these reference ranges used in
various papers are difficult to reconcile, but the use of a broader range
might be appropriate after treatment in hyperthyroid cats.
Symmetric dimethylarginine and creatinine showed good correla-
tion, in agreement with previous reports.17–19 Our population showed
a high number of discordant results, 35% of samples were classified
differently based on 1 or the other measurement. We found that
SDMA was more often increased with normal creatinine than the
other way around, in agreement with a previous study.19 All the cats
with increased SDMA and creatinine within the reference range were
documented to have renal azotemia (elevated creatinine and USG
<1.035) at a previous time point. However, 5% of samples in our
population had increased creatinine (presumed to represent a reduced
GFR) with SDMA within reference range, in contrast to a previous
study that found the sensitivity of SDMA for a 30% reduction from
median GFR to be consistently higher than that of creatinine.19 In
part, this may stem from a lower reference interval for creatinine in
the laboratory used in the present study than that used previously (ie,
2.0 mg/dL as opposed to 2.1 mg/dL).19 Closer inspection of the data
for the discordant samples with high creatinine (and normal SDMA)
revealed USG <1.035 in many of the cats, supporting the presence of
renal azotemia. Although the influence of prerenal factors on creati-
nine cannot be discounted, this suggests that SDMA could be mislead-
ing in some cats with renal azotemia.
Assessment of SDMA and creatinine revealed a linear relation-
ship. The GEE indicated that SDMA concentrations were related not
only to creatinine concentrations but also to thyroid status. Specifi-
cally, the slope of the relationship between SDMA and creatinine was
steeper (ie, SDMA was relatively higher) in hyperthyroid cats com-
pared with euthyroid and hypothyroid cats. This is in contrast to the
weak negative relationship of tT4 to both SDMA and creatinine found
in a recent study.33 This could be because of the effect of thyroid hor-
mones on muscle mass15,20,21 with a resultant decrease in creatinine
production. However, only bodyweight, and not BCS, was found to be
significant. Alternatively, thyroid hormones alter cellular metabolism
and protein turnover,34 and the effect of low thyroid hormone levels
in reducing endogenous production of creatinine has been previously
reported.35 Thyroid hormones might also have direct effects on
SDMA generation, as demonstrated for cystatin C in hyperthyroid
cats,36 and in humans, SDMA concentrations have been found to be
increased with either hyperthyroidism or hypothyroidism.37,38 A rela-
tively mild effect of bodyweight on the relationship of SDMA and cre-
atinine was also present, in contrast to previous reports20,21 with
higher bodyweight associated with relatively lower SDMA concentra-
tions compared to creatinine. The use of SDMA as a surrogate for
GFR, therefore, has limitations, much as seen with the use of creati-
nine. It seems likely that thyroid status influences the concentrations
of creatinine and SDMA, both relative to GFR and to 1 another.
Unfortunately, for this retrospective study, gold standard assessment
of renal function by GFR measurement was not available. Evaluation
of BCS was recorded for only 92 of the 151 samples, and no record
was made of muscle mass score. It is possible therefore that missing
data could be the reason that there was an association with body-
weight but not BCS.
A major limitation of this retrospective study was the availability of
samples, and the desired length of follow-up, necessitating the use of
samples that had been in storage for years (72/151 samples were
stored for 10 years or more at −80C) and some of which had under-
gone 1 or 2 freeze-thaw cycles. Although data on the stability of feline
biochemical markers and hormones is limited for this length of storage,
there is evidence for stability of T4 in frozen canine samples over
5 days of storage.39 Thyroid stimulating hormone and fT4 are stable in
frozen human serum for 13 months and for up to 29 years.40,41 Stored
samples have been used previously for analysis of SDMA in studies in
2014 and 2016,19,42 although the length of time stored was not speci-
fied, the samples were noted to be from 2010 and after, suggesting
some could have been 4-6 years old. Symmetric dimethylarginine is
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stable over 3 freeze-thaw cycles in canine samples.43 Further studies to
assess the stability of measurement for hormone and renal markers in
stored feline samples would be welcomed.
In summary, after thyroidectomy, a high percentage of cats can
develop recurrent hyperthyroidism. Cats can experience recovery of
thyroid function, or progression to hyperthyroidism, for years after
surgery. Cats that regained normal thyroid function often showed a
lag phase, where TSH remained increased but tT4 had normalized.
Conversely, when TSH is undetectably low, it is frequently, although
not always, a harbinger of recurrent hyperthyroidism.
Symmetric dimethylarginine and creatinine are strongly linearly
related, as would be anticipated as they are both good estimates of
GFR; however, they are also influenced by thyroid status. The associa-
tion cannot be explained by changes in body weight or BCS. Further
studies are required to evaluate the effect of hyperthyroidism on
SDMA, ideally incorporating GFR estimation.
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